Posts Tagged ‘cardiovascular risk reduction’

Heart Benefits of Semaglutide Are More Than Weight Loss

October 24, 2025 — A new study in Lancet tells us that we need a fundamental reframing of the medical benefits semaglutide can bring to a growing number of people around the world. In the simplest terms, researchers have found that the heart benefits of semaglutide actually have relatively little to do with weight loss. Professor John Deanfield was […]

Ania Jastreboff on the Transformation of Obesity Care

A Conversation with Dr. Ania Jastreboff About the SELECT Trial

November 16, 2023 — It was an amazing moment. Hundreds upon hundreds people packed into huge convention hall to hear about the detailed outcomes of the first ever randomized controlled trial to show that treating obesity could prevent heart attacks, strokes, and cardiovascular deaths. The implications of the SELECT trial for obesity care will be enormous and we had […]